Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117360) titled 'The safety and efficacy of cryoablation combined with immune checkpoint inhibitors in advanced non-small cell lung cancer' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
Lung cancer
Intervention:
CT-guided percutaneous cryoablation:CT-guided percutaneous cryoablation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: CT-guided percutaneous cryoablation:20;Bronchoscopic cryoablation group:20;
Countries of Recruitment:
China
To k...